These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19836370)

  • 61. Mouse models of human diseases.
    Westphal H
    Curr Opin Biotechnol; 1991 Dec; 2(6):830-3. PubMed ID: 1367956
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Autopsy and histological analysis of the transgenic mouse.
    Gijbels MJ; de Winther MP
    Methods Mol Biol; 2011; 693():75-87. PubMed ID: 21080275
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Protocols for assessing neurodegenerative phenotypes in Alzheimer's mouse models.
    Kang J; Watanabe H; Shen J
    STAR Protoc; 2021 Sep; 2(3):100654. PubMed ID: 34286289
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Transgenic and knockout mice in the study of neurodegenerative diseases.
    Aguzzi A; Brandner S; Marino S; Steinbach JP
    J Mol Med (Berl); 1996 Mar; 74(3):111-26. PubMed ID: 8846161
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Transgenic mouse models of Alzheimer disease: developing a better model as a tool for therapeutic interventions.
    Kitazawa M; Medeiros R; Laferla FM
    Curr Pharm Des; 2012; 18(8):1131-47. PubMed ID: 22288400
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The cell cycle hypothesis of Alzheimer's disease: suggestions for drug development.
    Woods J; Snape M; Smith MA
    Biochim Biophys Acta; 2007 Apr; 1772(4):503-8. PubMed ID: 17223322
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Why have transgenic rodent models failed to successfully mimic Alzheimer's disease. How can we develop effective drugs without them?
    Franco R; Martínez-Pinilla E; Navarro G
    Expert Opin Drug Discov; 2019 Apr; 14(4):327-330. PubMed ID: 30775940
    [No Abstract]   [Full Text] [Related]  

  • 68. Moving towards a more realistic concept of what constitutes Alzheimer's disease.
    Hölscher C
    EBioMedicine; 2019 Jan; 39():17-18. PubMed ID: 30579866
    [No Abstract]   [Full Text] [Related]  

  • 69. Relevance of transgenic mouse models to human Alzheimer disease.
    Morrissette DA; Parachikova A; Green KN; LaFerla FM
    J Biol Chem; 2009 Mar; 284(10):6033-7. PubMed ID: 18948253
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Transgenic mouse models.
    Skelton J; Gower LH; McGough A; Labosky PA
    Methods Mol Biol; 2013; 1032():1-17. PubMed ID: 23943440
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Alzheimer's disease: a tale of two diseases?
    Nardini E; Hogan R; Flamier A; Bernier G
    Neural Regen Res; 2021 Oct; 16(10):1958-1964. PubMed ID: 33642366
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Animal models of Alzheimer's disease for preclinical research.].
    Takahashi H
    Nihon Yakurigaku Zasshi; 2010 Jul; 136(1):6-10. PubMed ID: 20628206
    [No Abstract]   [Full Text] [Related]  

  • 73. Restricting mealtime ameliorates neurodegeneration.
    Tian X; Sinclair DA
    Cell Metab; 2023 Oct; 35(10):1673-1674. PubMed ID: 37793341
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A cross-species analysis method to analyze animal models' similarity to human's disease state.
    Yu S; Zheng L; Li Y; Li C; Ma C; Li Y; Li X; Hao P
    BMC Syst Biol; 2012; 6 Suppl 3(Suppl 3):S18. PubMed ID: 23282076
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The complexities of behavioural assessment in neurodegenerative disorders: A focus on Alzheimer's disease.
    Commins S; Kirby BP
    Pharmacol Res; 2019 Sep; 147():104363. PubMed ID: 31374247
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Commentary on "Diagnosis of Alzheimer's disease: two decades of progress". Alzheimer's disease research: new opportunities for early diagnosis and drug discovery.
    Trojanowski JQ; Lee VM
    Alzheimers Dement; 2005 Oct; 1(2):119-20. PubMed ID: 19595841
    [No Abstract]   [Full Text] [Related]  

  • 77. Understanding gene functions and disease mechanisms: Phenotyping pipelines in the German Mouse Clinic.
    Fuchs H; Aguilar-Pimentel JA; Amarie OV; Becker L; Calzada-Wack J; Cho YL; Garrett L; Hölter SM; Irmler M; Kistler M; Kraiger M; Mayer-Kuckuk P; Moreth K; Rathkolb B; Rozman J; da Silva Buttkus P; Treise I; Zimprich A; Gampe K; Hutterer C; Stöger C; Leuchtenberger S; Maier H; Miller M; Scheideler A; Wu M; Beckers J; Bekeredjian R; Brielmeier M; Busch DH; Klingenspor M; Klopstock T; Ollert M; Schmidt-Weber C; Stöger T; Wolf E; Wurst W; Yildirim AÖ; Zimmer A; Gailus-Durner V; Hrabě de Angelis M
    Behav Brain Res; 2018 Oct; 352():187-196. PubMed ID: 28966146
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Genetically Engineered Animal Models of Alzheimer's Disease.
    Higgins LS; Cordell B
    Methods; 1996 Dec; 10(3):384-91. PubMed ID: 8954850
    [TBL] [Abstract][Full Text] [Related]  

  • 79. What have we learnt from past failures in Alzheimer's disease drug discovery?
    Cacabelos R
    Expert Opin Drug Discov; 2022 Apr; 17(4):309-323. PubMed ID: 35129021
    [No Abstract]   [Full Text] [Related]  

  • 80. Toward a better understanding of mouse models of disease.
    Sellers RS; Ward JM
    Vet Pathol; 2012 Jan; 49(1):4. PubMed ID: 22215683
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.